Terry Pirovolakis

Company: Elpida Therapeutics

Job title: Founder & Chief Executive Officer

Bio:

Elpida Therapeutics SPC: A social purpose corporation registered in California, was established by Mr. Pirovolakis in response to this significant unmet need, with the intention of advancing non-commercially viable, ultra-rare conditions from proof-of-concept to BLA to provide treatments for underprivileged children. This is accomplished through philanthropy and in-kind partnerships with top biotech, CDMO, and CRO organizations in the gene therapy field. Elpida operates as a non-profit, using all profits to support further programs. Presently, Elpida Therapeutics is working on SPG50, CMT4J, and CLN7, with two additional programs to be chosen via an application process and a scientific expert committee to advance academic and foundation programs

Seminars:

Panel Discussion: Establishing Multistakeholder-Relevant Clinical Endpoints 11:30 am

How can we ensure clinical trial endpoints are meaningful to patients, agreeable to regulators, and measurable to payers Considerations for internal team structuring to ensure endpoints are relevant to all stakeholders Understanding EMA and FDA differences in deeming an outcome ‘clinically meaningful’Read more

day: Clinical - AM

First-Hand Experiences of the Clinical Trial Process 3:30 pm

Outlining the decision-making process: assessing risks, benefits, and drivers for commencing a clinical trial Reflecting on the burden of participating: which elements of the experience were de-stressed and where could improvements be made in the future? Assessing levels of communication from healthcare providers throughout How can drug developers help to empower patients to partner with them…Read more

day: Day Two PM